Jefferies Financial Group Inc. reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 83.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 584 shares of the medical equipment provider’s stock after selling 3,042 shares during the period. Jefferies Financial Group Inc.’s holdings in Intuitive Surgical were worth $237,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of the business. Bank of America Corp DE lifted its position in shares of Intuitive Surgical by 3.3% in the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp acquired a new position in Intuitive Surgical in the 2nd quarter valued at approximately $1,335,753,000. Amundi increased its stake in Intuitive Surgical by 8.6% in the 1st quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after buying an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership increased its stake in Intuitive Surgical by 95.3% in the 1st quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after buying an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. lifted its position in Intuitive Surgical by 10.8% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after buying an additional 184,044 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.
Insider Activity at Intuitive Surgical
In related news, SVP Patricia L. Wadors sold 1,078 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $443.80, for a total value of $478,416.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig H. Barratt sold 1,150 shares of the company’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $510,370.00. Following the completion of the sale, the director owned 1,150 shares of the company’s stock, valued at $510,370. This represents a 50.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 39,379 shares of company stock worth $17,739,043 over the last quarter. 0.60% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
A number of brokerages have issued reports on ISRG. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research note on Monday, July 20th. Piper Sandler reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. Mizuho cut their price objective on Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating for the company in a report on Wednesday, October 21st. KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Finally, Wells Fargo & Company reissued an “overweight” rating and set a $486.00 price objective (down from $487.00) on shares of Intuitive Surgical in a research report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $493.54.
Check Out Our Latest Stock Analysis on Intuitive Surgical
Intuitive Surgical Stock Performance
NASDAQ:ISRG opened at $437.75 on Tuesday. The stock’s 50 day moving average price is $419.01 and its 200 day moving average price is $429.55. Intuitive Surgical, Inc. has a 52 week low of $328.57 and a 52 week high of $603.88. The company has a market capitalization of $151.74 billion, a P/E ratio of 52.93, a P/E/G ratio of 3.03 and a beta of 1.45.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion during the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s revenue was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company earned $2.40 earnings per share. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.
See Also
- Five stocks we like better than Intuitive Surgical
- Ondas Is Building a Defense Growth Engine, But Can It Deliver on Its Backlog?
- Orbiting Growth: Federal Contracts Boost Viasat’s Outlook
- Modine Manufacturing Scales Up to Solve the AI Heat Problem
- Nebius Revenue Is Surging, But Its Spending Is Raising Bigger Questions
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
